Search

Your search keyword '"Neumann, Uta"' showing total 146 results

Search Constraints

Start Over You searched for: Author "Neumann, Uta" Remove constraint Author: "Neumann, Uta"
146 results on '"Neumann, Uta"'

Search Results

2. Satisfaction with a new patient education program for children, adolescents, and young adults with differences of sex development (DSD) and their parents.

4. Development and evaluation of a patient education programme for children, adolescents, and young adults with differences of sex development (DSD) and their parents: study protocol of Empower-DSD

5. Self- and proxy-reported outcomes after surgery in people with disorders/differences of sex development (DSD) in Europe (dsd-LIFE)

7. Temporal Trends in Acute Adrenal Insufficiency Events in Children With Congenital Adrenal Hyperplasia During 2019-2022

8. Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients

9. Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach

10. Intersexual Twins due to Tetragametic Chimerism

11. The genetic diagnosis of rare endocrine disorders of sex development and maturation: a survey among Endo-ERN centres

16. Blood pressure (BP) status in Congenital Adrenal Hyperplasia (CAH) – longitudinal analysis of real world data from the I-CAH registry

19. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry

20. Treatment of congenital adrenal hyperplasia in children aged 0–3 years: a retrospective\ud multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure

21. Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe

22. The genetic diagnosis of rare endocrine disorders of sex development and maturation:a survey among Endo-ERN centres

23. Treatment of congenital adrenal hyperplasia in children aged 0–3 years:A retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure

24. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry

25. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry

26. The genetic diagnosis of rare endocrine disorders of sex development and maturation: a survey among Endo-ERN centres

27. Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe

28. Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis

29. Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients

30. International practice of therapy monitoring in congenital adrenal hyperplasia - Real World data from the I-CAH registry

31. Variation of glucocorticoid dose and biomarkers in children with congenital adrenal hyperplasia longitudinal analysis of real world data from the I-CAH registry

32. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry

34. Real world estimates of adrenal insufficiency related adverse events in children with congenital adrenal hyperplasia

36. Self- and proxy-reported outcomes after surgery in people with disorders/differences of sex development (DSD) in Europe (dsd-LIFE)

38. Rationale of a lower dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling

39. Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21-hydroxylase deficiency in Europe

40. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia:Data from the I-CAH registry

41. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: Data from the I-CAH registry

42. Real-World Estimates of Adrenal Insufficiency-Related Adverse Events in Children with Congenital Adrenal Hyperplasia

43. Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21‑hydroxylase deficiency in Europe

45. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry

46. Diagnosis of DSD in Children—Development of New Tools for a Structured Diagnostic and Information Management Program within the Empower-DSD Study.

47. Response to ‘Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia’

48. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children

49. Real-World Estimates of Adrenal Insufficiency–Related Adverse Events in Children With Congenital Adrenal Hyperplasia

Catalog

Books, media, physical & digital resources